Sagar, India

Santosh Richhariya

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ranbaxy Laboratories, Inc., Sun Pharmaceutical Industries Limited. Active years: 2013-2021.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Sagar, IN (2013 - 2015)
  • Madhya Pradesh, IN (2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Santosh Richhariya: Innovator in Pharmaceutical Processes

Introduction

Santosh Richhariya is a notable inventor based in Sagar, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on innovative processes for drug preparation, which are crucial for the development of effective medications.

Latest Patents

Richhariya's latest patents include a process for the preparation of ixazomib citrate, which provides a method for synthesizing this important compound. Additionally, he has developed a process for the preparation of fosamprenavir calcium, further showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Santosh Richhariya has worked with prominent companies in the pharmaceutical industry, including Ranbaxy Laboratories, Inc. and Sun Pharmaceutical Industries Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation.

Collaborations

Some of his notable coworkers include Hashim Nizar Poovanathil Nagoor Meeran and Satish Manohar Bhoge. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

In summary, Santosh Richhariya is a distinguished inventor whose work in pharmaceutical processes has led to valuable patents and advancements in drug preparation. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…